All News

Jeremy Abramson, MD, director of the Jon and Jo Ann Hagler Center for Lymphoma at the Massachusetts General Hospital Cancer Center, shared his take on the potential benefits of chimeric antigen receptor (CAR) T-cell therapy in earlier lines of treatment.

Gregory Vidal, MD, PhD, director of Clinical Research at West Cancer Center & Research Institute, spoke about community-level discussions within diversity, equity, and inclusion to be addressed at the 8th Annual West Oncology Conference.

Tochi M. Okwuosa, DO, cardiologist and director of cardio-oncology at Rush University Medical, discusses the multidisciplinary process that underlies caring for patients with cancer who may develop heart damage.

Five leading academic cancer centers are assessing the feasibility of implementing the Health Equity Report Card pilot project as a tool that can both meaningfully and feasibly measure and report on equitable care practices.

Sharon Gill, MBA, chief visionary officer, Total Health, reviewed the agenda and key topics to be presented at the West Oncology Conference in Memphis, Tennessee, which takes place February 4-5, 2023.

Having models like these that produce more plausible results are crucial for decision-making in an era of targeted treatments that often come with immature data, argued researchers of their findings for minimal residual disease (MRD) in newly diagnosed multiple myeloma (NDMM).

The bill could have saved CMS about $26.5 billion had it been in place from 2018-2020, the study showed.

Approximately 70% of veterans with drug-resistant epilepsy reported diagnosis of at least 1 psychiatric condition, with female patients showing a higher prevalence than male patients.

The approval is based on results from the phase 3 TROPiCS-02 trial demonstrating overall and progression survival benefits with sacituzumab govitecan compared with physician’s choice of single-agent chemotherapy.

Despite overall improvements in survival outcomes in recent decades, disparities in survival outcomes persist among children and young adults with acute lymphocytic leukemia (ALL) across racial and ethnic groups.

CDC warns against EzriCare Artificial Tears, which were recalled by the manufacturer; certain weight loss drugs not covered by most payers; Mississippi's Republican governor denies being privately in support of Medicaid expansion.

At the start of the COVID-19 pandemic, high levels of distress, overwhelm with daily problems, and unmet psychosocial information needs decreased caregiver-reported health-related quality of life in children with rare diseases.

Younger patients with type 1 diabetes (T1D) and comorbid post-traumatic stress disorder (PTSD) faced the strongest negative impact on certain T1D outcomes compared with patients without PTSD or general mental comorbidities.

Paul G. Alexander, MD, MPH, executive vice president and chief health equity and transformation officer, RWJBarnabas Health, discusses how community partnerships helped ameliorate disparities in health care access and accessibility, as well as food and travel insecurities amid the COVID-19 pandemic.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

The study suggests there is measurable amount of microbiome within the soft tissue sarcoma tumor environment, which was previously thought to be sterile.

Amy Crawford-Faucher, MD, vice chair of the Primary Care Institute and Department of Family Medicine at Allegheny Health Network, discussed treatment of respiratory syncytial virus (RSV) without a vaccine and what a future vaccine could mean for older adults.

With atopic dermatitis (AD) prevalence increasing around the world, primarily in developing countries, investigators evaluated the potential for pollution to have an impact on development of the chronic skin condition among an adult population.

Edward Partridge, MD, chief medical officer of Guideway Care, spoke on his organization’s 25-year history in addressing cancer disparities and the crucial role that care navigators/guides have in achieving value-based care within oncology.

A new study aimed to assess the quality and reliability of videos uploaded to YouTube that provide information around spinal muscular atrophy (SMA).

Merck & Co. and Eli Lilly & Co. report sales loss for COVID-19 treatments; Republican state attorneys general tell CVS and Walgreens that mailing mifepristone might break the law; exposure to air pollution over time is associated with a rise in incidence of depression and anxiety.

A DNA sequencing analysis associated Q192R polymorphism in the paraoxonase 1 gene with female infertility in Saudi women.

Asthma management strategies should focus on accessible, affordable, and quality care, primarily in low-income and middle-income settings, study finds.

Known to be a contributing factor to polyp development at high levels, periostin’s potential as a biomarker for eosinophilic chronic rhinosinusitis (ECRS) severity was investigated in a new study in which outcomes were compared between patients who had ECRS and those with non-ECRS.

Health care expert and lived experience panels came to a consensus on several aspects that should be considered in the decision to offer and continue active surveillance for prostate cancer.

Research showed that a mean of 19.5%, 17.1%, and 43.3% of adults with diabetes did not maintain continuity in use of medications to lower glucose, blood pressure, or lipid levels, respectively.

Compared with patients with poor continuous positive airway pressure (CPAP) compliance, patients with good CPAP compliance saw improvements in lung function after 12 months.

Behavioral and combined behavioral and pharmacological interventions were investigated for their potential to help improve sleep outcomes in children with attention-deficit/hyperactivity disorder (ADHD).

The exact reasons for the links are not yet clear, although some evidence suggests inflammation plays a role.

A review and meta-analysis published in the journal Radiology found MRI to be the most effective supplemental breast cancer screening method for women with dense breasts and negative mammogram results.